Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03467659 · ClinicalTrials.gov registry record · NA
Whole Grains, Gastric Emptying and Glycemic Response
A NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT03467659: Completed NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by Purdue University.
NCT03467659 is a NA study of Obesity and Diabetes Mellitus, Type 2 that has completed, run by Purdue University. The registered enrollment target is 16 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03467659, a NA study of Obesity and Diabetes Mellitus, Type 2, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Whole grains have been associated with controlled glycemic response and increased satiety compared to refined grains. However, the properties of whole grains which are responsible for these purported improved health outcomes are still unclear. The current study investigated the extent of whole grains' low glycemic property when food properties are controlled, and how this relates to gastric emptying rate and glycemic response.
Primary Outcome
Breath test was performed using 13C-octanoic acid mixed into test meals
Conditions Studied
Interventions
- OTHER Cracked whole wheat porridge
- OTHER Semolina wheat porridge
- OTHER Whole wheat flour porridge
- OTHER Refined wheat flour porridge
- OTHER Refined wheat flour porridge,fine bran
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-02-16 |
| Est. Completion | 2017-05-31 |
| Phase | NA |
What the finished NCT03467659 record still lists
NCT03467659 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Cracked whole wheat porridge is the first listed.
NCT03467659 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03467659 about?
NCT03467659 is a clinical study titled "Whole Grains, Gastric Emptying and Glycemic Response". Whole grains have been associated with controlled glycemic response and increased satiety compared to refined grains. However, the properties of whole grains which are responsible for these purported improved health outcomes are still unclear. The current study investigated the extent of whole grain...
What is the current status of trial NCT03467659?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-02-16. Estimated completion is 2017-05-31.
What conditions does trial NCT03467659 study?
This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2, Appetitive Behavior.
What interventions are being tested in trial NCT03467659?
The interventions under investigation include: Cracked whole wheat porridge (OTHER), Semolina wheat porridge (OTHER), Whole wheat flour porridge (OTHER), Refined wheat flour porridge (OTHER), Refined wheat flour porridge,fine bran (OTHER).
Who is sponsoring clinical trial NCT03467659?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03467659 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03467659's enrollment target sits among peer trials
16 993rd of 1053 higher than 56 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI